Outcomes for persons with triple-class resistant HIV and a history of virologic failure.

Saved in:
Bibliographic Details
Title: Outcomes for persons with triple-class resistant HIV and a history of virologic failure.
Authors: Ingle SM; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.. Electronic address: s.ingle@bristol.ac.uk., Bonnet F; CHU de Bordeaux, Hôpital Saint André, Service de Médecine Interne et Maladies, Infectieuses, 33075 Bordeaux, France.; Bordeaux Population Health Research Center, INSERM U1219, CIC-EC 1401, Univ. Bordeaux - ISPED, 33076, Bordeaux, France., Wittkop L; Univ. Bordeaux, INSERM, BPH, U1219, CIC-EC 1401, F-33000, Bordeaux, France.; INRIA SISTM team, Talence, France.; CHU de Bordeaux, Service d'information médicale, INSERM, France., Calmy A; HIV Unit, Division of Infectious Diseases, Geneva University Hospitals, Switzerland., Teira R; Service of Internal Medicine, Hospital Universitario de Sierrallana, Torrelavega, Spain., Rebeiro PF; Vanderbilt University School of Medicine, Nashville, TN, USA., Crane HM; Center for AIDS Research, University of Washington, Seattle, WA, USA., Stephan C; Infectious Diseases, Department of Internal Medicine, University Hospital Frankfurt, Frankfurt, Germany., van der Valk M; Amsterdam UMC, location University of Amsterdam, Amsterdam Institute for Immunology & Infectious diseases and Stichting HIV monitoring, Amsterdam, the Netherlands., Boesecke C; Department of Medicine I, Bonn University Hospital, Bonn, Germany., Touloumi G; Department of Hygiene, Epidemiology & Medical Statistics, Medical School, National & Kapodistrian University of Athens, Greece., Gill MJ; Department of Medicine University of Calgary, Alberta, Canada., Grabmeier-Pfistershammer K; Medical University of Innsbruck, Innsbruck, Austria., Garcia F; Servicio de Microbiología Clínica, Hospital Universitario Clínico San Cecilio, Granada. Instituto de investigacion biosanitaria ibs. Granada. CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III. Spain., Ceccherini-Silberstein F; Department of Experimental Medicine, University of Rome Tor Vergata, Italy., Burkholder G; University of Alabama, Birmingham, US., Trickey A; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK., Sterne JAC; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK., Hessamfar M; CHU de Bordeaux, Hôpital Saint André, Service de Médecine Interne et Maladies, Infectieuses, 33075 Bordeaux, France.; Bordeaux Population Health Research Center, INSERM U1219, CIC-EC 1401, Univ. Bordeaux - ISPED, 33076, Bordeaux, France.
Corporate Authors: Antiretroviral Therapy Cohort Collaboration (ART-CC)
Source: International journal of antimicrobial agents [Int J Antimicrob Agents] 2026 Jul 13, pp. 107925. Date of Electronic Publication: 2026 Jul 13.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 9111860 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7913 (Electronic) Linking ISSN: 09248579 NLM ISO Abbreviation: Int J Antimicrob Agents Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1872-7913
DOI:10.1016/j.ijantimicag.2026.107925